Study points to the need to personalize pain-relief approach.

Neurology experts reviewed the latest evidence to offer new recommendations for management of painful neuropathy in diabetes patients.

The method could be an alternative to opioids and other medication.

Patients prescribed benzodiazepines and opioids by different providers 20% more likely to overdose, adding to already heightened risk.

Study looks at trends before and after 2016 guide for prescribers was released.

The cannabis-derived substance provides fewer side effects, with less potential for abuse.